Cantel Medical Corp.
If you purchased Cantel Medical Corp. securities and would like to join the action, please click "Join This Action" below.
CANTEL MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE SALE OF CANTEL MEDICAL CORP. IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – CMD
January 12, 2021.
New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether Cantel Medical Corp. (NYSE: CMD) and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Cantel to STERIS plc for $16.93 in cash and 0.33787 of a STERIS ordinary share.
On behalf of Cantel shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.